<VariationArchive RecordType="classified" VariationID="1338769" VariationName="NM_020822.3(KCNT1):c.1424_1485dup (p.Asn496delinsProGlyProTer)" VariationType="Duplication" Accession="VCV001338769" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-02-03" MostRecentSubmission="2023-07-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1329805" VariationID="1338769">
      <GeneList>
        <Gene Symbol="KCNT1" FullName="potassium sodium-activated channel subfamily T member 1" GeneID="57582" HGNC_ID="HGNC:18865" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="135702185" stop="135795502" display_start="135702185" display_stop="135795502" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="138594030" stop="138684992" display_start="138594030" display_stop="138684992" Strand="+" />
          </Location>
          <OMIM>608167</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020822.3(KCNT1):c.1424_1485dup (p.Asn496delinsProGlyProTer)</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="135768850" stop="135768851" display_start="135768850" display_stop="135768851" variantLength="62" positionVCF="135768850" referenceAlleleVCF="G" alternateAlleleVCF="GCCTGGGCCGTGAAGGACTTCGCCCCCAACTGCCCCCTCTACGTCCAGATCCTCAAACCTGAA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="138660696" stop="138660697" display_start="138660696" display_stop="138660697" variantLength="62" positionVCF="138660696" referenceAlleleVCF="G" alternateAlleleVCF="GCCTGGGCCGTGAAGGACTTCGCCCCCAACTGCCCCCTCTACGTCCAGATCCTCAAACCTGAA" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033070.1" sequenceAccession="NG_033070" sequenceVersion="1" change="g.71667_71728dup">
            <Expression>NG_033070.1:g.71667_71728dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001272003.2" sequenceAccession="NM_001272003" sequenceVersion="2" change="c.1289_1350dup">
            <Expression>NM_001272003.2:c.1289_1350dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258932.1" sequenceAccession="NP_001258932" sequenceVersion="1" change="p.Asn451delinsProGlyProTer">
            <Expression>NP_001258932.1:p.Asn451delinsProGlyProTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020822.3" sequenceAccession="NM_020822" sequenceVersion="3" change="c.1424_1485dup" MANESelect="true">
            <Expression>NM_020822.3:c.1424_1485dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065873.2" sequenceAccession="NP_065873" sequenceVersion="2" change="p.Asn496delinsProGlyProTer">
            <Expression>NP_065873.2:p.Asn496delinsProGlyProTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.138660697_138660758dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.138660697_138660758dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.135768851_135768912dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.135768851_135768912dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2131497737" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020822.3(KCNT1):c.1424_1485dup (p.Asn496delinsProGlyProTer) AND KCNT1-related channelopathy" Accession="RCV001822988" Version="1">
        <ClassifiedConditionList TraitSetID="72315">
          <ClassifiedCondition>KCNT1-related channelopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020822.3(KCNT1):c.1424_1485dup (p.Asn496delinsProGlyProTer) AND Developmental and epileptic encephalopathy, 14" Accession="RCV003314020" Version="1">
        <ClassifiedConditionList TraitSetID="9029">
          <ClassifiedCondition DB="MedGen" ID="C3554195">Developmental and epileptic encephalopathy, 14</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-15" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-30" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2022-02-03" MostRecentSubmission="2023-07-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2023-07-18">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="72315" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="61543" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">KCNT1-related channelopathy</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9029" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17499" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 14</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 14</ElementValue>
                <XRef ID="MONDO:0013989" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE14</ElementValue>
                <XRef Type="MIM" ID="614959" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">KCNT1-related epilepsy is most often associated with two phenotypes: epilepsy of infancy with migrating focal seizures (EIMFS) and autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). EIMFS is characterized by seizures, typically focal and asynchronous, beginning in the first six months of life with associated developmental plateau or regression. Autonomic manifestations (e.g., perioral cyanosis, flushing, apnea) are common. Seizures are intractable to multiple anticonvulsants and progress to become nearly continuous by age six to nine months. ADNFLE is characterized by clusters of nocturnal motor seizures that vary from simple arousals to hyperkinetic events with tonic or dystonic features. Individuals with KCNT1-related ADNFLE are more likely to develop seizures at a younger age, have cognitive comorbidity, and display psychiatric and behavioral problems than individuals with ADNFLE resulting from other causes. Less common seizure phenotypes in individuals with KCNT1-related epilepsy include West syndrome, Ohtahara syndrome, early myoclonic encephalopathy, leukodystrophy and/or leukoencephalopathy, focal epilepsy, and multifocal epilepsy. Additional neurologic features include hypotonia, microcephaly developing by age 12 months, strabismus, profound developmental delay, and additional movement disorders. Other systemic manifestations including pulmonary hemorrhage caused by prominent systemic-to-pulmonary collateral arteries or cardiac arrhythmia have been reported.</Attribute>
                <XRef ID="NBK525917" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15886" />
                <XRef ID="15886" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30234941</ID>
                <ID Source="BookShelf">NBK525917</ID>
              </Citation>
              <XRef ID="293181" DB="Orphanet" />
              <XRef ID="C3554195" DB="MedGen" />
              <XRef ID="MONDO:0013989" DB="MONDO" />
              <XRef Type="MIM" ID="614959" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4061649" SubmissionDate="2022-01-31" DateLastUpdated="2022-02-03" DateCreated="2022-02-03">
        <ClinVarSubmissionID localKey="SUB11015688" submittedAssembly="GRCh37" title="SUB11015688" />
        <ClinVarAccession Accession="SCV002072484" DateUpdated="2022-02-03" DateCreated="2022-02-03" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics, National &amp; Kapodistrian University of Athens" OrgID="506664" OrganizationCategory="laboratory" OrgAbbreviation="LMG-NKUA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNT1">
              <Name>potassium sodium-activated channel subfamily T member 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020822.3:c.1424_1485dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">KCNT1-related channelopathy</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11015688</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7512806" SubmissionDate="2023-07-18" DateLastUpdated="2023-07-22" DateCreated="2023-07-22">
        <ClinVarSubmissionID localKey="NM_020822.3:c.1424_1485dup|OMIM:614959" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004013989" DateUpdated="2023-07-22" DateCreated="2023-07-22" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics, National &amp; Kapodistrian University of Athens" OrgID="506664" OrganizationCategory="laboratory" OrgAbbreviation="LMG-NKUA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>PVS1, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020822.3:c.1424_1485dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614959" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13692901</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4061649" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512806" TraitType="Disease" MappingType="XRef" MappingValue="614959" MappingRef="OMIM">
        <MedGen CUI="C3554195" Name="Developmental and epileptic encephalopathy, 14" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4061649" TraitType="Disease" MappingType="Name" MappingValue="KCNT1-related channelopathy" MappingRef="Preferred">
        <MedGen CUI="None" Name="KCNT1-related channelopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

